CONCLUSIONS
▪
Our hypothesis of benefit of cisplatin based concomitant
chemo-radiation in FIGO Stage IIIB is proven
▪
Concomitant cisplatin based chemo-radiation resulted in
signficantly improved disease free & overall survivals with
an absolute benefit of 8.5 % and 8% respectively in FIGO
Stage III B (Squmaous cell carcinoma) Cervical Cancer
JAMA Oncol. Feb 2018




